EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib

Lucía Pérez-Lamas, Adrián Segura Díaz, Elvira Mora Casterá, Marta Hidalgo Soto, Antonio Paz Coll, Natalia De Las Heras, Montse Cortes, Patricia Vélez Tenza, Magdalena Sierra Pacho, Alicia Senin Magan, Anna Angona, Carlos Cervero und 6 weitere

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-05906-6 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Annals of Hematology, 2024. Verfasst von Lucía Pérez-Lamas und 17 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario Puerta de Hierro, Madrid, Spain. Hauptthemen laut MEDLINE: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Protein Kinase Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveProtein Kinase InhibitorsHumansMaleFemaleMiddle AgedRetrospective StudiesAgedAdultDrug Resistance, NeoplasmTreatment FailureTreatment OutcomePyridazinesTyrosine Kinase InhibitorsImidazolesNiacinamidePyrazoles

Stichwörter der Autor:innen

AsciminibChronic myeloid leukemiaConventional tyrosine kinase inhibitorsIntoleranceReal world settingResistance

Substanzen

Protein Kinase InhibitorsasciminibponatinibPyridazinesTyrosine Kinase InhibitorsImidazolesNiacinamidePyrazoles

Autor:innen und Institutionen

  • Hospital Universitario Puerta de Hierro, Madrid, Spain.
  • Hospital Universitario de Gran Canaria Doctor Negrín, Gran Canaria, Spain.
  • Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Hospital Universitario Vall d´Hebron, Barcelona, Spain.
  • Hospital Universitario Puerto Real, Puerto Real, Spain.
  • Hospital Universitario de León, León, Spain.

Zitieren

APA

Pérez-Lamas, L., Díaz, A. S., Casterá, E. M., Soto, M. H., Coll, A. P., De Las Heras, N., Cortes, M., Tenza, P. V., Pacho, M. S., Magan, A. S., Angona, A., Cervero, C., de Paz, R., Cuenca, A. S., Santaliestra, M., Marín, J. L., Casado, L. F., & García-Gutiérrez, V. (2024). Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib. Annals of Hematology. https://doi.org/10.1007/s00277-024-05906-6

Vancouver

Pérez-Lamas L, Díaz AS, Casterá EM, Soto MH, Coll AP, De Las Heras N, et al. Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib. Annals of Hematology. 2024. doi:10.1007/s00277-024-05906-6

BibTeX
@article{PrezLamas2024,
  author = {Pérez-Lamas, Lucía and Díaz, Adrián Segura and Casterá, Elvira Mora and Soto, Marta Hidalgo and Coll, Antonio Paz and De Las Heras, Natalia and Cortes, Montse and Tenza, Patricia Vélez and Pacho, Magdalena Sierra and Magan, Alicia Senin and Angona, Anna and Cervero, Carlos and de Paz, Raquel and Cuenca, Araceli Salamanca and Santaliestra, Marta and Marín, Javier López and Casado, Luis Felipe and García-Gutiérrez, Valentín},
  title = {Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-05906-6}
}
Kostenlos starten →